biosimilars

Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Biopharma Reporter
Mon, 08/21/23 - 06:50 pm
Novartis
Sandoz
spinoff
biosimilars
generics
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Fri, 08/18/23 - 11:29 am
Novartis
Sandoz
spinoffs
generics
biosimilars
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration
What’s Next In Biologics? Biosimilar Expert Predicts Big Fall Changes
Forbes
Fri, 08/11/23 - 10:06 am
biologics
biosimilars
legislation
Amgen's hyped Humira biosimilar fritters away its exclusivity advantage
Fierce Pharma
Fri, 08/4/23 - 11:56 am
Amgen
AbbVie
biosimilars
Humira
Biogen looks at selling biosims unit to longtime ally Samsung Bioepis: reports
Fierce Pharma
Thu, 08/3/23 - 09:59 am
Biogen
biosimilars
M&A
Samsung Bioepis
Despite big Q2 declines for Humira and Imbruvica, AbbVie still boosts earnings guidance
Fierce Pharma
Thu, 07/27/23 - 11:37 pm
AbbVie
earnings
Humira
biosimilars
Imbruvica
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Fierce Pharma
Mon, 07/24/23 - 09:35 pm
Teva Pharmaceutical
Alvotech
biosimilars
Humira
AbbVie
drug manufacturing
Four Crucial Questions about the Humira Biosimilar Price War
Drug Channels
Tue, 07/18/23 - 11:38 am
AbbVie
Humira
biosimilars
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Mark Cuban's online pharmacy set to launch Humira biosimilar
Reuters
Fri, 07/7/23 - 06:53 am
biosimilars
Mark Cuban
Mark Cuban Cost Plus Drugs
AbbVie
Humira
Coherus Biosciences
Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M
BioSpace
Wed, 07/5/23 - 11:44 am
Pfizer
Samsung BioLogics
drug manufacturing
biosimilars
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Fri, 06/30/23 - 11:39 am
Alvotech
Teva Pharmaceutical
AbbVie
Humira
biosimilars
FDA
Sandoz targets barriers to biosimilar accessibility with latest initiative
Pharmaceutical Technology
Thu, 06/15/23 - 07:00 pm
Sandoz
Novartis
patient access
biosimilars
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Fierce Pharma
Thu, 06/15/23 - 06:55 pm
AbbVie
Humira
biosimilars
Mark Cuban Cost Plus Drugs
Coherus Biosciences
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
Herceptin shows biosimilar markets can work. To what extent is the question.
Medical Marketing and Media
Sun, 06/11/23 - 11:12 pm
Herceptin
biosimilars
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Thu, 06/8/23 - 09:29 pm
Novartis
Sandoz
generics
biosimilars
Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing
Pharmaceutical Business Review
Thu, 06/8/23 - 09:45 am
Samsung BioLogics
Pfizer
biosimilars

Pages